This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2011 by Mahidol University.
Recruitment status was:  Recruiting
National Research Council of Thailand
Information provided by:
Mahidol University Identifier:
First received: May 1, 2010
Last updated: August 2, 2011
Last verified: August 2011

The purpose of this study is to study the efficacy of allergen injection immunotherapy for allergic rhinitis by

  • symptoms score
  • medication score
  • quality of life
  • immunologic test from blood

Condition Intervention Phase
Rhinitis, Allergic, Perennial Biological: Mite allergen extract Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Efficacy of Mite Allergen Vaccine Among Thai Patients With Allergic Rhinitis

Further study details as provided by Mahidol University:

Primary Outcome Measures:
  • Total nasal symptoms score [ Time Frame: average within 1 week ]

    3 point scale (0,1,2,3) and combination of

    • nasal block
    • rhinorrhea
    • itching
    • sneezing

Secondary Outcome Measures:
  • Combined total symptoms score and medication score [ Time Frame: average within 1 week ]
    Total symptom score (nasal block, rhinorrhea, itching, sneezing, and eye symptoms with chest symptoms = Maximal score --> 18 devided by 6 = 3) PLUS medication score ( antihistamine = 1, topical nasal steroid = 2; --> Maximal score = 3).

Estimated Enrollment: 100
Study Start Date: March 2010
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Placebo injection
Placebo injection with standard medication (oral antihistamine and/or topical nasal steroid)
Biological: Mite allergen extract
Dermatophagoides pteronyssinus from ALK company
Other Name: Allegen extract (D.p) from ALK company. 10,000 AU/ml

Detailed Description:

Compare the efficacy of allergen injection immunotherapy between the treatment group and the placebo group after injection for

  • 2 months
  • 6 months
  • 12 months

Ages Eligible for Study:   12 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • patients with the symptoms of allergic rhinitis who sensitized to mite (Dermatophagoides pteronyssinus)
  • positive skin prick test to D.p. at 4+ degree

Exclusion Criteria:

  • steroid dependent asthma
  • force expiratory volume (FEV1) less than 70% of predicted value
  • previous injection immunotherapy within 2 years
  • pregnancy
  • medical conditions such as ischemic heart disease, autoimmune disease, cancer, previous history of anaphylaxis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01115595

Contact: Pongsakorn Tantilipikorn, M.D. +66 2 419 7409
Contact: Bangon Pinkaew, M.Sc. +66 2 4197409

Division of Allergy and Rhinology, Faculty of Medicine Siriraj, Mahidol University Recruiting
Bangkok, Thailand, 10700
Contact: Bangon Pinkaew, M.Sc.    +66 2 419 7409   
Sponsors and Collaborators
Mahidol University
National Research Council of Thailand
Principal Investigator: Pongsakorn Tantilipikorn, M.D. Division of allergy and rhinology, Faculty of Medicine Siriraj, Mahidol University
  More Information

Responsible Party: National Research Council of Thailand Identifier: NCT01115595     History of Changes
Other Study ID Numbers: 336/2552
Study First Received: May 1, 2010
Last Updated: August 2, 2011

Keywords provided by Mahidol University:
Allergic rhinitis
Allergen injection immunotherapy

Additional relevant MeSH terms:
Rhinitis, Allergic
Rhinitis, Allergic, Perennial
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases processed this record on September 20, 2017